期刊文献+

平阳霉素注射治疗血管瘤致过敏性休克总结 被引量:5

Summary of pingyangmycin injection treatment for hemangioma result in anaphylactic shock
下载PDF
导出
摘要 目的:总结分析平阳霉素注射治疗血管瘤病例中过敏性休克病例,为临床预防和减少过敏性休克发生提供参考。方法:通过回顾性分析我院1991年至2012年6 029例平阳霉素注射治疗血管瘤病例中发生过敏性休克患者的临床病例资料。结果:过敏性休克多发生于注射治疗后10 min内,门诊注射后观察30 min后离院,可有效避免严重过敏性休克;注射前静推地塞米松可降低过敏性休克的发生,增加疗效;多次注射易发生过敏性休克(发生率约0.83‰),过敏性休克患者血清特异性Ig E均阳性、总免疫球蛋白E(Ig E)均明显增高。结论:平阳霉素多次注射可因变应原累及致敏作用而发生过敏性休克,但其发生率极低且可控。 Objective: The purpose is to summarize and analyze the anaphylactic shock cases in pingyangmycin injection therapy of hemangioma,in order to provide reference for preventing and reducing the anaphylactic shock in clinic. Methods: The method is to retrospectively analyze the data of the patients subjected to the anaphylactic shock in 6029 clinical cases in our hospital about injecting the pingyangmycin to treat hemangioma from 1991 to 2012. Results: The anaphylactic shock usually occurs within 10 minutes after the injection therapy,so the patient with such anaphylactic shock should get the injection treatment in out-patient department and remain in hospital under observation and can leave 30 minutes later,and therefore,severe anaphylactic shock can be effectively avoided. Before injection,dexamethasone should be subjected to intravenous injection in order to reduce the adverse effect as well as improving the treatment effect. Multi-injection might cause anaphylactic shock( about 0. 83% occurrence rate). The serologicalspecificity Ig E of the patient subjected to the anaphylactic shock is positive,and the whole immune globulin E( Ig E) obviously increased. Conclusion: Injecting the pingyangmycinat many times might cause allergen accumulative sensitization effect,resulting in the anaphylactic shock; however,the anaphylactic shock is relatively low in occurrence rate and is controllable.
出处 《川北医学院学报》 CAS 2014年第6期571-574,共4页 Journal of North Sichuan Medical College
基金 四川省卫生厅科研课题(100135)
关键词 平阳霉素 血管瘤 过敏性休克 Pingyangmycin Hemangioma Anaphylactic shock
  • 相关文献

参考文献6

二级参考文献23

  • 1贾暮云,金志勤,唐友盛,樊功为,尚伟.平阳霉素治疗颌面部海绵状血管瘤24例临床报告[J].中华口腔医学杂志,1994,29(5):294-296. 被引量:89
  • 2秦中平,任莉,李克雷,刘学键,胡秀启.婴幼儿血管瘤和血管畸形的临床鉴别诊断[J].中华口腔医学杂志,2005,40(4):280-283. 被引量:17
  • 3寿柏泉,杨震,孟昭业,南福清,郑葆春.平阳霉素治疗颌面部草莓状和混合性血管瘤225例的临床总结[J].华西口腔医学杂志,1995,13(3):198-200. 被引量:63
  • 4白南,陈远征,陈石海,郭树忠.平阳霉素治疗血管瘤的应用与研究[J].中国美容医学,2006,15(2):198-200. 被引量:21
  • 5Muir T, Kirsten M, Fourie P, et al. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations[J]. Pediatr Surg Int, 2004,19:766-773.
  • 6Zhi K, Wen Y, Li L, et al. The role of intralesional Pingyangmycin in the treatment of venous malformation of facial and maxillary region[J]. Int J Pediatr Otorhinolaryngol, 2008,72(5):593-597.
  • 7Zhao JH, Zhang WF, Zhao YF. Sclerotherapy of oral and facial venous malformations with use of piugyangmycin and/or sodium morrhuate[J]. Int J Oral Maxillofac Surg, 2004, 33:463-466.
  • 8Sung MW, Chang SO, Choi JH, et al. Bleomycin sclerotherapy in patients with congenital lymphatic malformation in the head and neck[J]. Am J Otolaryngol, 1995, 16(4):236-241.
  • 9胡亚美 江载芳.诸福棠实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1514.
  • 10Bartoshesky LE .Corticosteroid treatment of cutaneous hemangiomas: how effective ? a report on 24 children [J]. Clin Pediatr, 1978,17:625~628.

共引文献79

同被引文献50

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部